Gastric gastrointestinal stromal tumors. Is there a necessity to use imatinib in the intermediate-risk group? Posted on January 13, 2023January 31, 2023 by admin RESEARCH ARTICLE Hippokratia 2021, 25(3): 113-118 Yalav O, Gumus S, Gul MO, Eray IC, Rencuzogullari A Department of General Surgery, Department of Surgical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey